Time-varying risk of microvascular complications in latent autoimmune diabetes of adulthood compared with type 2 diabetes in adults: a post-hoc analysis of the UK Prospective Diabetes Study 30-year follow-up data (UKPDS 86)
- PMID: 32032540
- DOI: 10.1016/S2213-8587(20)30003-6
Time-varying risk of microvascular complications in latent autoimmune diabetes of adulthood compared with type 2 diabetes in adults: a post-hoc analysis of the UK Prospective Diabetes Study 30-year follow-up data (UKPDS 86)
Abstract
Background: Latent autoimmune diabetes of adulthood (LADA) differs in clinical features from type 2 diabetes. Whether this difference translates into different risks of complications remains controversial. We examined the long-term risk of microvascular complications in people enrolled in the UK Prospective Diabetes Study (UKPDS), according to their diabetes autoimmunity status.
Methods: We did a post-hoc analysis of 30-year follow-up data from UKPDS (UKPDS 86). UKPDS participants with diabetes autoantibody measurements available and without previous microvascular events were included. Participants with at least one detectable autoantibody were identified as having latent autoimmune diabetes, and those who tested negative for all autoantibodies were identified as having type 2 diabetes. The incidence of the primary composite microvascular outcome (first occurrence of renal failure, renal death, blindness, vitreous haemorrhage, or retinal photocoagulation) was compared between adults with latent autoimmune diabetes and those with type 2 diabetes. The follow-up ended on Sept 30, 2007. Baseline and updated 9-year mean values of potential confounders were tested in Cox models to adjust hazard ratios (HRs). UKPDS is registered at the ISRCTN registry, 75451837.
Findings: Among the 5028 participants included, 564 had latent autoimmune diabetes and 4464 had type 2 diabetes. After median 17·3 years (IQR 12·6-20·7) of follow-up, the composite microvascular outcome occurred in 1041 (21%) participants. The incidence for the composite microvascular outcome was 15·8 (95% CI 13·4-18·7) per 1000 person-years in latent autoimmune diabetes and 14·2 (13·3-15·2) per 1000 person-years in type 2 diabetes. Adults with latent autoimmune diabetes had a lower risk of the composite outcome during the first 9 years of follow-up than those with type 2 diabetes (adjusted HR 0·45 [95% CI 0·30-0·68], p<0·0001), whereas in subsequent years their risk was higher than for those with type 2 diabetes (1·25 [1·01-1·54], p=0·047). Correcting for the higher updated 9-year mean HbA1c seen in adults with latent autoimmune diabetes than in those with type 2 diabetes explained entirely their subsequent increased risk for the composite microvascular outcome (adjusted HR 0·99 [95% CI 0·80-1·23], p=0·93).
Interpretation: At diabetes onset, adults with latent autoimmune diabetes have a lower risk of microvascular complications followed by a later higher risk of complications than do adults with type 2 diabetes, secondary to worse glycaemic control. Implementing strict glycaemic control from the time of diagnosis could reduce the later risk of microvascular complications in adults with latent autoimmune diabetes.
Funding: European Foundation for the Study of Diabetes Mentorship Programme (AstraZeneca).
Copyright © 2020 Elsevier Ltd. All rights reserved.
Comment in
-
Latent autoimmune diabetes of adulthood: time to take action.Lancet Diabetes Endocrinol. 2020 Mar;8(3):177-179. doi: 10.1016/S2213-8587(20)30029-2. Epub 2020 Feb 4. Lancet Diabetes Endocrinol. 2020. PMID: 32032539 No abstract available.
Similar articles
-
Diabetes-Related Macrovascular Complications Are Associated With an Increased Risk of Diabetic Microvascular Complications: A Prospective Study of 1518 Patients With Type 1 Diabetes and 20 802 Patients With Type 2 Diabetes in the UK Biobank.J Am Heart Assoc. 2024 Jun 4;13(11):e032626. doi: 10.1161/JAHA.123.032626. Epub 2024 May 31. J Am Heart Assoc. 2024. PMID: 38818935
-
Long-term risk of cardiovascular disease in individuals with latent autoimmune diabetes in adults (UKPDS 85).Diabetes Obes Metab. 2019 Sep;21(9):2115-2122. doi: 10.1111/dom.13788. Epub 2019 Jun 19. Diabetes Obes Metab. 2019. PMID: 31099472
-
An insight into the recent diabetes trials: what is the best approach to prevent macrovascular and microvascular complications?Curr Diabetes Rev. 2013 Sep;9(5):371-81. doi: 10.2174/15733998113099990077. Curr Diabetes Rev. 2013. PMID: 23865412 Review.
-
Haemoglobin A1c--a marker for complications of type 2 diabetes: the experience from the UK Prospective Diabetes Study (UKPDS).Clin Chem Lab Med. 2003 Sep;41(9):1182-90. doi: 10.1515/CCLM.2003.182. Clin Chem Lab Med. 2003. PMID: 14598868 Review.
-
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.Lancet. 1998 Sep 12;352(9131):837-53. Lancet. 1998. PMID: 9742976 Clinical Trial.
Cited by
-
Association between low birth weight and impaired glucose tolerance in children: a systematic review and meta-analysis.Front Pediatr. 2024 May 9;12:1362076. doi: 10.3389/fped.2024.1362076. eCollection 2024. Front Pediatr. 2024. PMID: 38783917 Free PMC article.
-
The association of islet autoantibodies with the neural retinal thickness and microcirculation in type 1 diabetes mellitus with no clinical evidence of diabetic retinopathy.Acta Diabetol. 2024 Jul;61(7):897-907. doi: 10.1007/s00592-024-02255-8. Epub 2024 Mar 26. Acta Diabetol. 2024. PMID: 38530415
-
All-Cause Mortality and Cardiovascular and Microvascular Diseases in Latent Autoimmune Diabetes in Adults.Diabetes Care. 2023 Oct 1;46(10):1857-1865. doi: 10.2337/dc23-0739. Diabetes Care. 2023. PMID: 37635682 Free PMC article.
-
The relationship between red blood cell distribution width and islet β-cell function indexes in patients with latent autoimmune diabetes in adults.BMC Endocr Disord. 2023 Aug 24;23(1):180. doi: 10.1186/s12902-023-01435-x. BMC Endocr Disord. 2023. PMID: 37620783 Free PMC article.
-
Identification and phenotypic characterization of patients with LADA in a population of southeast Mexico.Sci Rep. 2023 Apr 29;13(1):7029. doi: 10.1038/s41598-023-34171-2. Sci Rep. 2023. PMID: 37120620 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous